Main reason for the overselling is due to the China lockdowns impacting the company contracted to produce the drug. Not a fundamental sell down in any way, just market sentiment. At the current price this is a screaming buy.
- Forums
- ASX - By Stock
- NYR
- Ann: European Patent to be Granted for Cholesterol-Lowering Drug
Ann: European Patent to be Granted for Cholesterol-Lowering Drug, page-10
Featured News
Add NYR (ASX) to my watchlist
|
|||||
Last
5.6¢ |
Change
-0.007(11.1%) |
Mkt cap ! $10.20M |
Open | High | Low | Value | Volume |
6.3¢ | 6.3¢ | 5.6¢ | $6.557K | 112.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 159741 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 74205 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 159741 | 0.056 |
3 | 73641 | 0.055 |
1 | 26600 | 0.054 |
1 | 50000 | 0.052 |
1 | 310000 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 74205 | 1 |
0.060 | 10000 | 1 |
0.065 | 10000 | 1 |
0.068 | 9000 | 1 |
0.069 | 33333 | 1 |
Last trade - 15.30pm 05/07/2024 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |